evidence of hemorrhage within the spinal tumor and the absence of flow voids on MRI. Degenerative changes were seen in the lumbar spine at and below the level of the tumors.
Diagnosis of SAH as a result of spinal cord tumor was made, and resection was planned in the same inpatient setting.
Operation. The patient underwent T-12, L-1, and L-2 laminectomy, and after opening the dura mater, a wellorganized hematoma was encountered. Blood clots were removed, and a large hemorrhagic mass was seen at the L1-2 level along with another separate lesion superiorly, as already depicted on MRI, at the T-12 level. Hemorrhagic tumor was separated from the surrounding neural tissues using standard microsurgical technique (Fig. 3) . Residual blood clots and tumor tissues were gently separated from the cauda equina (Video 1).
ViDeo 1.
Intraoperative features and technique of excision of hemorrhagic schwannoma. After opening the dura, a well-organized hematoma was encountered, which was gently separated from the interstices of root bundles of the cauda equina. The hemorrhagic mass was moved away from neural tissue and excised, with sacrifice of the nerve root. A nonhemorrhagic proximal lesion was removed in a piecemeal fashion. Copyright Anil Nanda. Published with permission. Click here to view with Media Player. Click here to view with Quicktime.
The tumor was attached to a nerve root, which was sacrificed. The resected tumor was ovoid in shape and cystic in consistency with a tense glistening capsule. The tumor at the T-12 level was also completely resected in a piecemeal fashion.
On histology, the section of the hemorrhagic mass confirmed the diagnosis of schwannoma with a combination of Antoni A and B architecture. There were areas of fresh hemorrhage and focal necrosis. Immunohistochemistry was positive for S100 protein. The section of the proximal lesion also showed the characteristics of schwannoma (Fig. 4) .
Postoperative Course. The patient had an uneventful inpatient stay and was discharged on the 5th postoperative day. Nimodipine was given as a vasospasm prophylaxis at the time of presentation and was continued for 3 weeks' duration. At the 3-month follow-up, the patient reported significant improvement in his leg pain without any new episode of seizure; hence, subsequent angiography was deferred. The patient continued to use anti-seizure medications, which will be tapered over the next few months.
Discussion
Spinal causes are responsible for up to 1.5% of all cases of SAH, although a lower incidence has also been reported. 7, 16 Patients with SAH from spinal pathology present mainly in their 3rd decade. 12 Of the primary spinal cord tumors, ependymoma of the conus medullaris-cauda equina region is the most common cause of SAH, followed by schwannoma and rarely hemangioblastoma. 2, 4, 9, 11 In their review, Parmar et al. 12 identified 20 cases of spinal cord schwannoma, 7 cases of which presented with intracranial symptoms only. Patients with intracranial SAH usually present with meningism, headache, and mental status changes; however, the clinical presentation can be extremely variable, ranging from nearly asymptomatic to sudden death. The patient in our case did not have any cranial symptoms, although his history of seizures could have been associated with the intracranial hemorrhage caused by the undetected intraspinal schwannoma.
Many theories, both vascular and mechanical, have been proposed to understand the mechanism of hemorrhage from spinal tumors into the subarachnoid space. 4, 6, 11 According to the vascular theory, ecstatic and hyalinized vessels of the tumor may undergo spontaneous thrombosis, which results in tumor necrosis and hemorrhage. 11 Mechanical factors also explain the unusual presentation of SAH in spinal tumors, particularly at the cauda equina region. 4 The mechanical theory states that the abnormal movements between spinal tumor and cauda equina produce traction forces, which stretch the most superficial vascular structure, resulting in hemorrhage. 4, 11 This may explain the appearance of symptoms as a result of exertion in some cases. 11 In our case the SAH spontaneously developed, which may be explained by the mechanical factors described in the cauda equina region. The absence of hemorrhagic signs in the T-12 tumor also supports the mechanical theory. Degenerative changes of the spine in our patient also may have contributed to the mechanical stresses on the tumor, which has been discussed in an earlier report. 12 Intratumoral hemorrhage in spinal schwannoma is a rare occurrence. 3, 8, 15 Ichinose et al. 8 reviewed only 3 cases of solitary intratumoral hemorrhage, cases that presented exclusively with spinal symptoms and neurological deficit in the lower limbs. In our case, there was clinico-radiological and histological evidence of intratumoral hemorrhage with simultaneous intracranial SAH, which, to the best of our knowledge, has not been previously described. Magnetic resonance imaging gives useful information about the duration and type of hematoma. 1 In contrast to the hyperintense well-defined nonhemorrhagic schwannoma at the T-12 level, the hemorrhagic tumor had heterogeneous hypointensities on T2-weighted and T2 gradient echo images, which is suggestive of acute intratumoral hemorrhage. Low signal intensity seen on T2-weighted images was mainly due to the presence of deoxyhemoglobin.
1 Exacerbation of leg pain may have been associated with a recent hemorrhagic event within the tumor.
Conclusions
We suggest that spinal causes should always be ruled out in patients with angio-negative intracranial SAH. Magnetic resonance imaging is a sensitive imaging modality to detect intratumoral hemorrhage, and signal intensity within the tumor helps to assess the age of the hemorrhage. We also support the mechanical theory, which describes the abnormal stresses on cauda equina tumors leading to SAH, as in our case in which the lesion situated proximal to the cauda equina did not develop signs of hemorrhage. Degenerative changes in the spine may also play a role in the pathogenesis of intracranial SAH in spinal cord tumors.
